Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint Inhibitor
Clinical trial NCT04179110 · WITHDRAWN
Trial details
- NCT number
- NCT04179110
- Sponsor
- Yale University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2022-12-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.